ANI Pharmaceuticals将在古根海姆生物技术会议上发表演讲 新泽西州普林斯顿,2025年1月28日 (环球新闻) -- ANI Pharmaceuticals, Inc.(“ANI”或“公司”)(纳斯达克:ANIP)今天宣布,首席执行官兼总裁Nikhil Lalwani,和 GlobeNewswire01/29 05:30 瑞杰金融维持ANI Pharmaceuticals(ANIP.US)买入评级,维持目标价83美元 瑞...
ANI Pharmaceuticals Inc (ANIP) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus.
Use Futu NiuNiu to view ANI Pharmaceuticals (ANIP)'s stock price, real-time quotes, latest news, historical trend charts, financial information and quotes.
--(BUSINESS WIRE)--May 12, 2023-- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (“ANI” or the "Company") today announced the pricing of its previously announced underwritten public offering of 1,898,735 shares of its common stock at a public offering price of $39...
PRINCETON, N.J. and ATLANTA, Sept. 11, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) (“ANI”) and Alimera Sciences, Inc. (NASDAQ: ALIM) (“Alimera” or the “Company”) today jointly announced that they have scheduled the closing of the...
hidden value oct. 03, 2017 11:49 am et ani pharmaceuticals, inc. (anip) stock abbv 27 comments just the facts maam 232 follower s follow summary ani pharmaceuticals intentionally omits many of its licensing partnerships and some of its pipeline. some with potentially great value. libigel and...
ANI Pharmaceuticals ( ANIP ) as a "perilous reversal" (up big yesterday but down big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified ANI Pharmaceuticals as such a stock due to the following factors: ANIP has an average dollar-volume (as measured by av...
--(BUSINESS WIRE)--May 11, 2023-- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (“ANI”) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares to be sold in the offering will be offered b...
The Company serves various industries including engineering, procurement, and construction (EPC) firms, power plants, oil and gas refineries, chemical and petrochemical industries, pharmaceuticals, cement, fast-moving consumer goods (FMCG), breweries, fertilizers, the hospitality industry, construction, ...
Reshma Kewalramani, CEO, Vertex Pharmaceuticals Photo: Courtesy Vertex Pharmaceuticals Dr. Reshma Kewalramani leads Vertex Pharmaceuticals, a scientific powerhouse on the brink of its second act. Under her predecessor, Vertex revolutionized the treatment of cystic fibrosis. Kewalramani’s job is to m...